HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV ‐positive tumour cells-Reference-Cited by-同舟云学术

HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV ‐positive tumour cells

Published:2014-06-30 Issue:7 Volume:18 Page:1372-1380
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Van den Bergh Johan M. J.¹,Guerti Khadija²,Willemen Yannick¹,Lion Eva¹,Cools Nathalie¹,Goossens Herman³,Vorsters Alex⁴,Van Tendeloo Viggo F. I.¹,Anguille Sébastien¹,Van Damme Pierre⁴,Smits Evelien L. J. M.¹⁵

Affiliation:

1. Laboratory of Experimental Hematology Vaccine and Infectious Disease Institute (VAXINFECTIO) Faculty of Medicine & Health Sciences University of Antwerp Antwerp Belgium

2. Division of Immunology Department of Laboratory Medicine Antwerp University Hospital Edegem Belgium

3. Laboratory of Medical Microbiology Vaccine and Infectious Disease Institute (VAXINFECTIO) Faculty of Medicine & Health Sciences University of Antwerp Antwerp Belgium

4. Centre for the Evaluation of Vaccination (CEV) Vaccine and Infectious Disease Institute (VAXINFECTIO) Faculty of Medicine & Health Sciences University of Antwerp Antwerp Belgium

5. Center for Oncological Research Antwerp Faculty of Medicine & Health Sciences University of Antwerp Antwerp Belgium

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.12284

Reference40 articles.

1. EMA. Available athttp://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000721/human_med_000694.jsp***[and]***mid=WC0b01ac058001d124 London UK 2007.

2. FDA. Available athttp://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186959.htm Rockville MD 2009.

3. AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity

4. Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine

5. Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A nonlinear transport–diffusion model for the interactions between immune system cells and HPV-infected cells;Nonlinear Dynamics;2023-06-06

2. Single-dose HPV vaccine immunity: is there a role for non-neutralizing antibodies?;Trends in Immunology;2022-10

3. Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment;Frontiers in Immunology;2021-05-14

4. Enhancement of specific T-lymphocyte responses by monocyte-derived dendritic cells pulsed with E2 protein of human papillomavirus 16 and human p16INK4A;PeerJ;2020-05-20

5. Defective Regulation of Membrane TNFα Expression in Dendritic Cells of Glioblastoma Patients Leads to the Impairment of Cytotoxic Activity against Autologous Tumor Cells;International Journal of Molecular Sciences;2020-04-21